www.fdanews.com/articles/71122-gsk-investors-bring-paxil-lawsuit
GSK Investors Bring Paxil Lawsuit
April 15, 2005
GlaxoSmithKline (GSK) is facing a class action lawsuit in the U.S. from investors who allege it concealed problems with its antidepressant drug Paxil. They allege the firm violated securities laws by issuing "false or misleading public statements". It comes after studies found Paxil could increase the risk of suicidal behaviour in adolescents. GSK, which is also facing patient lawsuits over Paxil, said the allegations were "without merit." A spokesman for GSK, which in the past has defended the way it presented clinical research on Paxil, added that the company had not yet been served with a copy of the lawsuit.